Inventor
DEY DEBENDRANATH
US21 patents
⚠️ This page may combine multiple inventors who share the name “DEY DEBENDRANATH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BEXEL PHARMACEUTICALS INC
8 patentsUS6794401B2Sep 21, 2004
Amino acid phenoxy ethers
BEXEL PHARMACEUTICALS INC19 citations91
US7087576B2Aug 8, 2006
Dipeptide phenyl ethers
BEXEL PHARMACEUTICALS INC12 citations82
US7521465B2Apr 21, 2009
Diphenyl ether derivatives
BEXEL PHARMACEUTICALS INC14 citations80
US7781464B2Aug 24, 2010
Heterocyclic diphenyl ethers
BEXEL PHARMACEUTICALS INC7 citations68
US7521466B2Apr 21, 2009
Dipeptide phenyl ethers
BEXEL PHARMACEUTICALS INC2 citations60
US7456292B2Nov 25, 2008
Hydroxamic acid-containing amino acid derivatives
BEXEL PHARMACEUTICALS INC4 citations57
US7399786B2Jul 15, 2008
Derivatives of amino acids for treatment of obesity and related disorders
BEXEL PHARMACEUTICALS INC5 citations55
US7365069B2Apr 29, 2008
Pyrimidone derivatives
BEXEL PHARMACEUTICALS INC0 citations36
THERACOS INC
6 patentsUS7105552B2Sep 12, 2006
Heterocyclic analogs of diphenylethylene compounds
THERACOS INC10 citations73
US6855732B2Feb 15, 2005
Compounds to treat diabetes and associated conditions
THERACOS INC6 citations71
US7202366B2Apr 10, 2007
Heterocyclic analogs of diphenylethylene compounds
THERACOS INC2 citations62
US7407978B2Aug 5, 2008
Heterocyclic analogs of diphenylethylene compounds
THERACOS INC1 citations48
US7718682B2May 18, 2010
Heterocyclic analogs of diphenylethylene compounds
THERACOS INC0 citations47
US6723736B2Apr 20, 2004
Tricyclic compounds and uses thereof
THERACOS INC0 citations40
CALYX THERAPEUTICS INC
4 patentsUS6624197B1Sep 23, 2003
Diphenylethylene compounds
CALYX THERAPEUTICS INC36 citations92
US6331633B1Dec 18, 2001
Heterocyclic analogs of diphenylethylene compounds
CALYX THERAPEUTICS INC35 citations92
US6245814B1Jun 12, 2001
Diphenylethylene compounds
CALYX THERAPEUTICS INC35 citations92
US6525093B1Feb 25, 2003
Compounds to treat diabetes and associated conditions
CALYX THERAPEUTICS INC6 citations71